Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Asia Pacific Generic Injectables Market Size
The Asia Pacific generic injectables market was valued at USD 7.5 billion in 2023, driven by the increasing investment in the generic injectables sector and the rising healthcare needs. The market is expected to grow at a CAGR of 8.30% during the forecast period of 2024-2032, with the values likely to rise from USD 8.1 billion in 2024 to USD 15.3 billion by 2032.
Asia Pacific Generic Injectables Market Outlook
- Increased regulatory support leading to faster approvals of first-time generics and favorable government policies encouraging the uptake of generic injectables are influencing the market share significantly.
- In June 2023, RK Pharma Inc., received an investment of USD 200 million from a leading Asia-Pacific-based investment firm PAG to strengthen its position as a leading specialty injectable pharmaceutical company. Such substantial investment initiatives in the generic medication sector are likely to elevate the Asia Pacific generic injectables market value.
- Recent data reveals that Asia accounts for an alarming 45% of all global breast cancer cases and almost 58% of cervical cancer associated mortality globally. This surge in the burden of cancer and other chronic diseases is poised to fuel the demand for cost-effective healthcare solutions including generic injectables.
Asia Pacific Generic Injectables Market Report Snapshots
Asia Pacific Generic Injectables Market Size
Asia Pacific Generic Injectables Market Analysis
Asia Pacific Generic Injectables Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The market attained a value of about USD 7.5 billion in 2023 driven by the rising prevalence of chronic diseases in the region.
The market is anticipated to grow at a CAGR of 8.30% during the forecast period of 2024-2032, likely to reach a market value of USD 15.3 billion by 2032.
The growing geriatric population and increasing innovations in drug delivery systems are fuelling the demand for the market.
One of the significant trends in the market is increasing investment in the generic injectables sector. In June 2023, RK Pharma Inc., received an investment of USD 200 million from a leading Asia-Pacific-based investment firm to strengthen its position as a leading specialty injectable pharmaceutical company.
Based on the product type, the market is broadly segmented into large molecule injectables and small molecule injectables. Large molecule injectables are further divided into monoclonal antibodies (mAbs), and insulin, among others.
Container types available in the market include vials, premix, prefilled syringes, and ampoules, among others.
Major applications of the generic injectables include oncology, cardiovascular, CNS, infectious diseases, and autoimmune disorders, among others.
The market breakup by route of administration includes intravenous, intramuscular, and subcutaneous, among others.
Distribution channels of the market are hospitals and retail pharmacies, among others.
The market segmentation by countries includes China, Japan, India, ASEAN, and Australia, among others.
The key players in the market are Pfizer Inc., Baxter, Novartis Pharmaceuticals Corporation, Fresenius SE & Co. KGaA, Endo, Inc., Dr. Reddy’s Laboratories Ltd., Viatris Inc., Biocon, Sanofi, Lupin, Aurobindo Pharma Limited, and Sun Pharmaceutical Industries Ltd.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124